NCT00004005View on ClinicalTrials.gov

Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Carcinoma of Unknown PrimaryColorectal CancerUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

fluorouracil

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

PROCEDURE

conventional surgery

RADIATION

radiation therapy

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

St. Jude Children's Research Hospital

OTHER